nodes	percent_of_prediction	percent_of_DWPC	metapath
Telmisartan—ABCC2—Indinavir—acquired immunodeficiency syndrome	0.0524	0.0737	CbGbCtD
Telmisartan—ABCC2—Saquinavir—acquired immunodeficiency syndrome	0.046	0.0647	CbGbCtD
Telmisartan—ABCC2—Ritonavir—acquired immunodeficiency syndrome	0.046	0.0647	CbGbCtD
Telmisartan—ABCG2—Nelfinavir—acquired immunodeficiency syndrome	0.046	0.0647	CbGbCtD
Telmisartan—ABCG2—Ritonavir—acquired immunodeficiency syndrome	0.0416	0.0585	CbGbCtD
Telmisartan—ABCG2—Saquinavir—acquired immunodeficiency syndrome	0.0416	0.0585	CbGbCtD
Telmisartan—ABCG2—Zidovudine—acquired immunodeficiency syndrome	0.0399	0.0561	CbGbCtD
Telmisartan—ABCC2—Lamivudine—acquired immunodeficiency syndrome	0.0341	0.048	CbGbCtD
Telmisartan—ABCG2—Lamivudine—acquired immunodeficiency syndrome	0.0308	0.0434	CbGbCtD
Telmisartan—CYP2C19—Efavirenz—acquired immunodeficiency syndrome	0.0288	0.0406	CbGbCtD
Telmisartan—CYP2C19—Lopinavir—acquired immunodeficiency syndrome	0.0271	0.0381	CbGbCtD
Telmisartan—CYP2C19—Amprenavir—acquired immunodeficiency syndrome	0.0245	0.0345	CbGbCtD
Telmisartan—CYP2C19—Delavirdine—acquired immunodeficiency syndrome	0.0245	0.0345	CbGbCtD
Telmisartan—ABCB1—Lopinavir—acquired immunodeficiency syndrome	0.0219	0.0308	CbGbCtD
Telmisartan—CYP2C19—Indinavir—acquired immunodeficiency syndrome	0.0212	0.0298	CbGbCtD
Telmisartan—CYP2C19—Nelfinavir—acquired immunodeficiency syndrome	0.0205	0.0289	CbGbCtD
Telmisartan—ABCB1—Amprenavir—acquired immunodeficiency syndrome	0.0198	0.0278	CbGbCtD
Telmisartan—CYP2C19—Saquinavir—acquired immunodeficiency syndrome	0.0186	0.0261	CbGbCtD
Telmisartan—CYP2C19—Ritonavir—acquired immunodeficiency syndrome	0.0186	0.0261	CbGbCtD
Telmisartan—CYP2C19—Zidovudine—acquired immunodeficiency syndrome	0.0178	0.0251	CbGbCtD
Telmisartan—ABCB1—Indinavir—acquired immunodeficiency syndrome	0.0171	0.024	CbGbCtD
Telmisartan—ABCB1—Nelfinavir—acquired immunodeficiency syndrome	0.0166	0.0233	CbGbCtD
Telmisartan—ABCB1—Saquinavir—acquired immunodeficiency syndrome	0.015	0.0211	CbGbCtD
Telmisartan—ABCB1—Ritonavir—acquired immunodeficiency syndrome	0.015	0.0211	CbGbCtD
Telmisartan—ABCB1—Zidovudine—acquired immunodeficiency syndrome	0.0144	0.0202	CbGbCtD
Telmisartan—ABCB1—Lamivudine—acquired immunodeficiency syndrome	0.0111	0.0156	CbGbCtD
Telmisartan—AGTR1—endothelium—acquired immunodeficiency syndrome	0.00304	0.0756	CbGeAlD
Telmisartan—AGTR1—blood plasma—acquired immunodeficiency syndrome	0.0027	0.0671	CbGeAlD
Telmisartan—PPARG—endothelium—acquired immunodeficiency syndrome	0.0025	0.0622	CbGeAlD
Telmisartan—PPARG—blood plasma—acquired immunodeficiency syndrome	0.00222	0.0552	CbGeAlD
Telmisartan—CYP2C19—blood plasma—acquired immunodeficiency syndrome	0.00168	0.0417	CbGeAlD
Telmisartan—SLCO1B3—vagina—acquired immunodeficiency syndrome	0.00151	0.0376	CbGeAlD
Telmisartan—SLCO1B3—lung—acquired immunodeficiency syndrome	0.00143	0.0355	CbGeAlD
Telmisartan—PPARG—skin of body—acquired immunodeficiency syndrome	0.00107	0.0265	CbGeAlD
Telmisartan—AGTR1—lymphoid tissue—acquired immunodeficiency syndrome	0.00105	0.0261	CbGeAlD
Telmisartan—AGTR1—blood—acquired immunodeficiency syndrome	0.000991	0.0246	CbGeAlD
Telmisartan—AGTR1—vagina—acquired immunodeficiency syndrome	0.000918	0.0228	CbGeAlD
Telmisartan—AGTR1—lung—acquired immunodeficiency syndrome	0.000868	0.0216	CbGeAlD
Telmisartan—PPARG—lymphoid tissue—acquired immunodeficiency syndrome	0.000866	0.0215	CbGeAlD
Telmisartan—PPARG—digestive system—acquired immunodeficiency syndrome	0.000855	0.0212	CbGeAlD
Telmisartan—PPARG—blood—acquired immunodeficiency syndrome	0.000815	0.0202	CbGeAlD
Telmisartan—AGTR1—nervous system—acquired immunodeficiency syndrome	0.000804	0.02	CbGeAlD
Telmisartan—PPARG—bone marrow—acquired immunodeficiency syndrome	0.000788	0.0196	CbGeAlD
Telmisartan—AGTR1—central nervous system—acquired immunodeficiency syndrome	0.000774	0.0192	CbGeAlD
Telmisartan—PPARG—vagina—acquired immunodeficiency syndrome	0.000755	0.0187	CbGeAlD
Telmisartan—ABCC2—digestive system—acquired immunodeficiency syndrome	0.000752	0.0187	CbGeAlD
Telmisartan—ABCC2—blood—acquired immunodeficiency syndrome	0.000716	0.0178	CbGeAlD
Telmisartan—PPARG—lung—acquired immunodeficiency syndrome	0.000714	0.0177	CbGeAlD
Telmisartan—ABCB1—blood plasma—acquired immunodeficiency syndrome	0.000703	0.0174	CbGeAlD
Telmisartan—PPARG—nervous system—acquired immunodeficiency syndrome	0.000661	0.0164	CbGeAlD
Telmisartan—CYP2C19—digestive system—acquired immunodeficiency syndrome	0.000646	0.016	CbGeAlD
Telmisartan—PPARG—central nervous system—acquired immunodeficiency syndrome	0.000637	0.0158	CbGeAlD
Telmisartan—SLCO1B3—Transport of organic anions—ALB—acquired immunodeficiency syndrome	0.000635	0.0417	CbGpPWpGaD
Telmisartan—AGTR1—Peptide GPCRs—ACKR1—acquired immunodeficiency syndrome	0.000617	0.0405	CbGpPWpGaD
Telmisartan—CYP2C19—blood—acquired immunodeficiency syndrome	0.000615	0.0153	CbGeAlD
Telmisartan—AGTR1—brain—acquired immunodeficiency syndrome	0.000615	0.0153	CbGeAlD
Telmisartan—AGTR1—lymph node—acquired immunodeficiency syndrome	0.000594	0.0147	CbGeAlD
Telmisartan—CYP2C19—vagina—acquired immunodeficiency syndrome	0.00057	0.0142	CbGeAlD
Telmisartan—ABCG2—blood—acquired immunodeficiency syndrome	0.000522	0.013	CbGeAlD
Telmisartan—PPARG—brain—acquired immunodeficiency syndrome	0.000505	0.0125	CbGeAlD
Telmisartan—ABCG2—bone marrow—acquired immunodeficiency syndrome	0.000505	0.0125	CbGeAlD
Telmisartan—ABCG2—spinal cord—acquired immunodeficiency syndrome	0.000503	0.0125	CbGeAlD
Telmisartan—PPARG—lymph node—acquired immunodeficiency syndrome	0.000488	0.0121	CbGeAlD
Telmisartan—ABCG2—vagina—acquired immunodeficiency syndrome	0.000484	0.012	CbGeAlD
Telmisartan—AGTR1—Peptide ligand-binding receptors—CCL3L1—acquired immunodeficiency syndrome	0.000479	0.0315	CbGpPWpGaD
Telmisartan—SLCO1B3—Recycling of bile acids and salts—ALB—acquired immunodeficiency syndrome	0.00047	0.0309	CbGpPWpGaD
Telmisartan—ABCG2—lung—acquired immunodeficiency syndrome	0.000458	0.0114	CbGeAlD
Telmisartan—PPARG—Circadian rythm related genes—CARTPT—acquired immunodeficiency syndrome	0.00045	0.0296	CbGpPWpGaD
Telmisartan—ABCC2—lymph node—acquired immunodeficiency syndrome	0.000429	0.0107	CbGeAlD
Telmisartan—ABCB1—retina—acquired immunodeficiency syndrome	0.000385	0.00955	CbGeAlD
Telmisartan—AGTR1—Peptide GPCRs—CCR2—acquired immunodeficiency syndrome	0.000345	0.0227	CbGpPWpGaD
Telmisartan—AGTR1—Peptide GPCRs—CXCR4—acquired immunodeficiency syndrome	0.000324	0.0213	CbGpPWpGaD
Telmisartan—ABCG2—brain—acquired immunodeficiency syndrome	0.000324	0.00804	CbGeAlD
Telmisartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCL3L1—acquired immunodeficiency syndrome	0.000321	0.0211	CbGpPWpGaD
Telmisartan—ABCG2—lymph node—acquired immunodeficiency syndrome	0.000313	0.00777	CbGeAlD
Telmisartan—AGTR1—Allograft Rejection—CXCL12—acquired immunodeficiency syndrome	0.000308	0.0202	CbGpPWpGaD
Telmisartan—AGTR1—Peptide ligand-binding receptors—ACKR1—acquired immunodeficiency syndrome	0.00029	0.0191	CbGpPWpGaD
Telmisartan—ABCB1—lymphoid tissue—acquired immunodeficiency syndrome	0.000274	0.00679	CbGeAlD
Telmisartan—ABCB1—digestive system—acquired immunodeficiency syndrome	0.00027	0.00671	CbGeAlD
Telmisartan—AGTR1—Peptide ligand-binding receptors—CCL4—acquired immunodeficiency syndrome	0.000262	0.0172	CbGpPWpGaD
Telmisartan—ABCB1—blood—acquired immunodeficiency syndrome	0.000257	0.00639	CbGeAlD
Telmisartan—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—acquired immunodeficiency syndrome	0.00025	0.0164	CbGpPWpGaD
Telmisartan—ABCB1—bone marrow—acquired immunodeficiency syndrome	0.000249	0.00618	CbGeAlD
Telmisartan—ABCB1—spinal cord—acquired immunodeficiency syndrome	0.000248	0.00616	CbGeAlD
Telmisartan—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CSF2—acquired immunodeficiency syndrome	0.000247	0.0163	CbGpPWpGaD
Telmisartan—SLCO1B3—Bile acid and bile salt metabolism—ALB—acquired immunodeficiency syndrome	0.000246	0.0162	CbGpPWpGaD
Telmisartan—AGTR1—GPCR ligand binding—CCL3L1—acquired immunodeficiency syndrome	0.000245	0.0161	CbGpPWpGaD
Telmisartan—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL4—acquired immunodeficiency syndrome	0.000243	0.016	CbGpPWpGaD
Telmisartan—ABCB1—vagina—acquired immunodeficiency syndrome	0.000239	0.00592	CbGeAlD
Telmisartan—SLCO1B3—Transport of vitamins, nucleosides, and related molecules—ALB—acquired immunodeficiency syndrome	0.000235	0.0155	CbGpPWpGaD
Telmisartan—AGTR1—Allograft Rejection—IL10—acquired immunodeficiency syndrome	0.000233	0.0153	CbGpPWpGaD
Telmisartan—AGTR1—Allograft Rejection—CD40LG—acquired immunodeficiency syndrome	0.000233	0.0153	CbGpPWpGaD
Telmisartan—AGTR1—Allograft Rejection—IL4—acquired immunodeficiency syndrome	0.000227	0.0149	CbGpPWpGaD
Telmisartan—ABCB1—lung—acquired immunodeficiency syndrome	0.000226	0.0056	CbGeAlD
Telmisartan—AGTR1—Peptide GPCRs—CCR5—acquired immunodeficiency syndrome	0.000222	0.0146	CbGpPWpGaD
Telmisartan—AGTR1—Allograft Rejection—HLA-B—acquired immunodeficiency syndrome	0.000222	0.0146	CbGpPWpGaD
Telmisartan—ABCB1—nervous system—acquired immunodeficiency syndrome	0.000209	0.00519	CbGeAlD
Telmisartan—ABCB1—central nervous system—acquired immunodeficiency syndrome	0.000201	0.005	CbGeAlD
Telmisartan—PPARG—Regulation of retinoblastoma protein—CSF2—acquired immunodeficiency syndrome	0.000198	0.013	CbGpPWpGaD
Telmisartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—ACKR1—acquired immunodeficiency syndrome	0.000195	0.0128	CbGpPWpGaD
Telmisartan—ABCG2—HIF-1-alpha transcription factor network—CXCR4—acquired immunodeficiency syndrome	0.000193	0.0127	CbGpPWpGaD
Telmisartan—ABCG2—HIF-1-alpha transcription factor network—CXCL12—acquired immunodeficiency syndrome	0.000193	0.0127	CbGpPWpGaD
Telmisartan—PPARG—Transcription factor regulation in adipogenesis—TNF—acquired immunodeficiency syndrome	0.000184	0.0121	CbGpPWpGaD
Telmisartan—AGTR1—Peptide ligand-binding receptors—CCL3—acquired immunodeficiency syndrome	0.000179	0.0118	CbGpPWpGaD
Telmisartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCL4—acquired immunodeficiency syndrome	0.000176	0.0116	CbGpPWpGaD
Telmisartan—AGTR1—Peptide ligand-binding receptors—CCR2—acquired immunodeficiency syndrome	0.000162	0.0107	CbGpPWpGaD
Telmisartan—PPARG—RXR and RAR heterodimerization with other nuclear receptor—TNF—acquired immunodeficiency syndrome	0.000161	0.0106	CbGpPWpGaD
Telmisartan—ABCB1—brain—acquired immunodeficiency syndrome	0.00016	0.00397	CbGeAlD
Telmisartan—ABCB1—lymph node—acquired immunodeficiency syndrome	0.000154	0.00383	CbGeAlD
Telmisartan—AGTR1—Peptide ligand-binding receptors—CXCL12—acquired immunodeficiency syndrome	0.000152	0.01	CbGpPWpGaD
Telmisartan—AGTR1—Peptide ligand-binding receptors—CXCR4—acquired immunodeficiency syndrome	0.000152	0.01	CbGpPWpGaD
Telmisartan—PPARG—Transcription factor regulation in adipogenesis—IL6—acquired immunodeficiency syndrome	0.000148	0.00974	CbGpPWpGaD
Telmisartan—AGTR1—GPCR ligand binding—ACKR1—acquired immunodeficiency syndrome	0.000148	0.00974	CbGpPWpGaD
Telmisartan—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—acquired immunodeficiency syndrome	0.000147	0.00967	CbGpPWpGaD
Telmisartan—AGTR1—Allograft Rejection—IFNG—acquired immunodeficiency syndrome	0.000137	0.00901	CbGpPWpGaD
Telmisartan—AGTR1—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	0.000134	0.00881	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	0.000132	0.00866	CbGpPWpGaD
Telmisartan—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—acquired immunodeficiency syndrome	0.000131	0.00859	CbGpPWpGaD
Telmisartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—TNF—acquired immunodeficiency syndrome	0.000128	0.00841	CbGpPWpGaD
Telmisartan—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	0.000127	0.000544	CcSEcCtD
Telmisartan—Myalgia—Ritonavir—acquired immunodeficiency syndrome	0.000127	0.000544	CcSEcCtD
Telmisartan—AGTR1—GPCRs, Class A Rhodopsin-like—CCR2—acquired immunodeficiency syndrome	0.000127	0.00834	CbGpPWpGaD
Telmisartan—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	0.000127	0.000542	CcSEcCtD
Telmisartan—Anaemia—Lamivudine—acquired immunodeficiency syndrome	0.000127	0.000542	CcSEcCtD
Telmisartan—Anxiety—Ritonavir—acquired immunodeficiency syndrome	0.000127	0.000542	CcSEcCtD
Telmisartan—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	0.000126	0.00054	CcSEcCtD
Telmisartan—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	0.000126	0.00054	CcSEcCtD
Telmisartan—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.000126	0.000538	CcSEcCtD
Telmisartan—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.000126	0.000538	CcSEcCtD
Telmisartan—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.000126	0.000538	CcSEcCtD
Telmisartan—AGTR1—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	0.000126	0.00825	CbGpPWpGaD
Telmisartan—Anorexia—Delavirdine—acquired immunodeficiency syndrome	0.000126	0.000537	CcSEcCtD
Telmisartan—Discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000126	0.000537	CcSEcCtD
Telmisartan—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.000125	0.000537	CcSEcCtD
Telmisartan—Cough—Saquinavir—acquired immunodeficiency syndrome	0.000125	0.000536	CcSEcCtD
Telmisartan—Angioedema—Lamivudine—acquired immunodeficiency syndrome	0.000125	0.000536	CcSEcCtD
Telmisartan—Pain—Indinavir—acquired immunodeficiency syndrome	0.000125	0.000533	CcSEcCtD
Telmisartan—Constipation—Indinavir—acquired immunodeficiency syndrome	0.000125	0.000533	CcSEcCtD
Telmisartan—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.000124	0.000533	CcSEcCtD
Telmisartan—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.000124	0.000533	CcSEcCtD
Telmisartan—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	0.000124	0.000532	CcSEcCtD
Telmisartan—Hypertension—Saquinavir—acquired immunodeficiency syndrome	0.000124	0.000531	CcSEcCtD
Telmisartan—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.000124	0.00053	CcSEcCtD
Telmisartan—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.000124	0.00053	CcSEcCtD
Telmisartan—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000124	0.000529	CcSEcCtD
Telmisartan—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.000124	0.000529	CcSEcCtD
Telmisartan—Malaise—Lamivudine—acquired immunodeficiency syndrome	0.000124	0.000529	CcSEcCtD
Telmisartan—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000123	0.000528	CcSEcCtD
Telmisartan—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000123	0.000528	CcSEcCtD
Telmisartan—Vertigo—Lamivudine—acquired immunodeficiency syndrome	0.000123	0.000527	CcSEcCtD
Telmisartan—Hypotension—Delavirdine—acquired immunodeficiency syndrome	0.000123	0.000527	CcSEcCtD
Telmisartan—Syncope—Lamivudine—acquired immunodeficiency syndrome	0.000123	0.000526	CcSEcCtD
Telmisartan—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.000123	0.000525	CcSEcCtD
Telmisartan—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.000122	0.000524	CcSEcCtD
Telmisartan—Myalgia—Saquinavir—acquired immunodeficiency syndrome	0.000122	0.000523	CcSEcCtD
Telmisartan—Chest pain—Saquinavir—acquired immunodeficiency syndrome	0.000122	0.000523	CcSEcCtD
Telmisartan—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	0.000122	0.000523	CcSEcCtD
Telmisartan—Anxiety—Saquinavir—acquired immunodeficiency syndrome	0.000122	0.000522	CcSEcCtD
Telmisartan—AGTR1—Allograft Rejection—IL2—acquired immunodeficiency syndrome	0.000122	0.00801	CbGpPWpGaD
Telmisartan—Oedema—Ritonavir—acquired immunodeficiency syndrome	0.000122	0.000521	CcSEcCtD
Telmisartan—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000121	0.00052	CcSEcCtD
Telmisartan—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	0.000121	0.00052	CcSEcCtD
Telmisartan—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.000121	0.000519	CcSEcCtD
Telmisartan—Discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000121	0.000517	CcSEcCtD
Telmisartan—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	0.00012	0.000515	CcSEcCtD
Telmisartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	0.00012	0.0079	CbGpPWpGaD
Telmisartan—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.00012	0.000514	CcSEcCtD
Telmisartan—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.00012	0.000514	CcSEcCtD
Telmisartan—Shock—Ritonavir—acquired immunodeficiency syndrome	0.00012	0.000513	CcSEcCtD
Telmisartan—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	0.00012	0.000512	CcSEcCtD
Telmisartan—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	0.00012	0.000512	CcSEcCtD
Telmisartan—Cough—Lamivudine—acquired immunodeficiency syndrome	0.00012	0.000512	CcSEcCtD
Telmisartan—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.00012	0.000512	CcSEcCtD
Telmisartan—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	0.000119	0.000511	CcSEcCtD
Telmisartan—AGTR1—GPCRs, Class A Rhodopsin-like—CXCR4—acquired immunodeficiency syndrome	0.000119	0.00784	CbGpPWpGaD
Telmisartan—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	0.000119	0.00051	CcSEcCtD
Telmisartan—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000119	0.00051	CcSEcCtD
Telmisartan—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.000119	0.00051	CcSEcCtD
Telmisartan—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.000119	0.00051	CcSEcCtD
Telmisartan—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	0.000119	0.000509	CcSEcCtD
Telmisartan—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.000119	0.000509	CcSEcCtD
Telmisartan—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000119	0.000508	CcSEcCtD
Telmisartan—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.000119	0.000508	CcSEcCtD
Telmisartan—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	0.000118	0.000506	CcSEcCtD
Telmisartan—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	0.000118	0.000506	CcSEcCtD
Telmisartan—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.000118	0.000504	CcSEcCtD
Telmisartan—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.000118	0.000504	CcSEcCtD
Telmisartan—Pain—Efavirenz—acquired immunodeficiency syndrome	0.000118	0.000504	CcSEcCtD
Telmisartan—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000118	0.000504	CcSEcCtD
Telmisartan—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000118	0.000503	CcSEcCtD
Telmisartan—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.000117	0.000503	CcSEcCtD
Telmisartan—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000117	0.000503	CcSEcCtD
Telmisartan—Oedema—Saquinavir—acquired immunodeficiency syndrome	0.000117	0.000502	CcSEcCtD
Telmisartan—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.000117	0.000501	CcSEcCtD
Telmisartan—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000117	0.000501	CcSEcCtD
Telmisartan—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	0.000117	0.000499	CcSEcCtD
Telmisartan—Chest pain—Lamivudine—acquired immunodeficiency syndrome	0.000117	0.000499	CcSEcCtD
Telmisartan—Myalgia—Lamivudine—acquired immunodeficiency syndrome	0.000117	0.000499	CcSEcCtD
Telmisartan—Infection—Saquinavir—acquired immunodeficiency syndrome	0.000116	0.000498	CcSEcCtD
Telmisartan—Anxiety—Lamivudine—acquired immunodeficiency syndrome	0.000116	0.000498	CcSEcCtD
Telmisartan—Anorexia—Ritonavir—acquired immunodeficiency syndrome	0.000116	0.000497	CcSEcCtD
Telmisartan—AGTR1—Peptide ligand-binding receptors—CCL5—acquired immunodeficiency syndrome	0.000116	0.00762	CbGpPWpGaD
Telmisartan—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.000116	0.000496	CcSEcCtD
Telmisartan—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	0.000116	0.000496	CcSEcCtD
Telmisartan—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.000116	0.000495	CcSEcCtD
Telmisartan—Shock—Saquinavir—acquired immunodeficiency syndrome	0.000115	0.000494	CcSEcCtD
Telmisartan—Discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000115	0.000493	CcSEcCtD
Telmisartan—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.000115	0.000493	CcSEcCtD
Telmisartan—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.000115	0.000493	CcSEcCtD
Telmisartan—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	0.000115	0.000492	CcSEcCtD
Telmisartan—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000115	0.000492	CcSEcCtD
Telmisartan—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	0.000115	0.000491	CcSEcCtD
Telmisartan—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000115	0.00049	CcSEcCtD
Telmisartan—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	0.000114	0.00049	CcSEcCtD
Telmisartan—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	0.000114	0.000488	CcSEcCtD
Telmisartan—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000114	0.000488	CcSEcCtD
Telmisartan—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000114	0.000487	CcSEcCtD
Telmisartan—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	0.000114	0.000487	CcSEcCtD
Telmisartan—Hypotension—Ritonavir—acquired immunodeficiency syndrome	0.000114	0.000487	CcSEcCtD
Telmisartan—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.000114	0.000487	CcSEcCtD
Telmisartan—Rash—Stavudine—acquired immunodeficiency syndrome	0.000114	0.000486	CcSEcCtD
Telmisartan—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.000114	0.000486	CcSEcCtD
Telmisartan—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000114	0.000486	CcSEcCtD
Telmisartan—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.000113	0.000485	CcSEcCtD
Telmisartan—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	0.000113	0.000485	CcSEcCtD
Telmisartan—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000113	0.000485	CcSEcCtD
Telmisartan—Headache—Stavudine—acquired immunodeficiency syndrome	0.000113	0.000483	CcSEcCtD
Telmisartan—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000113	0.000483	CcSEcCtD
Telmisartan—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.000113	0.000482	CcSEcCtD
Telmisartan—Pain—Delavirdine—acquired immunodeficiency syndrome	0.000113	0.000482	CcSEcCtD
Telmisartan—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.000113	0.000482	CcSEcCtD
Telmisartan—PPARG—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	0.000112	0.00739	CbGpPWpGaD
Telmisartan—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000112	0.000481	CcSEcCtD
Telmisartan—Rash—Abacavir—acquired immunodeficiency syndrome	0.000112	0.000479	CcSEcCtD
Telmisartan—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000112	0.000479	CcSEcCtD
Telmisartan—Oedema—Lamivudine—acquired immunodeficiency syndrome	0.000112	0.000479	CcSEcCtD
Telmisartan—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	0.000112	0.000479	CcSEcCtD
Telmisartan—Anorexia—Saquinavir—acquired immunodeficiency syndrome	0.000112	0.000478	CcSEcCtD
Telmisartan—Headache—Abacavir—acquired immunodeficiency syndrome	0.000111	0.000476	CcSEcCtD
Telmisartan—Infection—Lamivudine—acquired immunodeficiency syndrome	0.000111	0.000475	CcSEcCtD
Telmisartan—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000111	0.000475	CcSEcCtD
Telmisartan—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000111	0.000475	CcSEcCtD
Telmisartan—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000111	0.000474	CcSEcCtD
Telmisartan—Insomnia—Ritonavir—acquired immunodeficiency syndrome	0.00011	0.000471	CcSEcCtD
Telmisartan—Shock—Lamivudine—acquired immunodeficiency syndrome	0.00011	0.000471	CcSEcCtD
Telmisartan—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	0.00011	0.000469	CcSEcCtD
Telmisartan—Hypotension—Saquinavir—acquired immunodeficiency syndrome	0.00011	0.000469	CcSEcCtD
Telmisartan—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	0.000109	0.000469	CcSEcCtD
Telmisartan—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	0.000109	0.000468	CcSEcCtD
Telmisartan—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.000109	0.000468	CcSEcCtD
Telmisartan—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.000109	0.000466	CcSEcCtD
Telmisartan—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.000109	0.000466	CcSEcCtD
Telmisartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	0.000109	0.00715	CbGpPWpGaD
Telmisartan—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	0.000109	0.000465	CcSEcCtD
Telmisartan—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.000109	0.000465	CcSEcCtD
Telmisartan—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.000109	0.000465	CcSEcCtD
Telmisartan—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.000108	0.000463	CcSEcCtD
Telmisartan—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	0.000108	0.000463	CcSEcCtD
Telmisartan—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.000108	0.000461	CcSEcCtD
Telmisartan—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000107	0.00046	CcSEcCtD
Telmisartan—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.000107	0.000459	CcSEcCtD
Telmisartan—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	0.000107	0.000459	CcSEcCtD
Telmisartan—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000107	0.000459	CcSEcCtD
Telmisartan—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000107	0.000458	CcSEcCtD
Telmisartan—PPARG—Generic Transcription Pathway—CCNT1—acquired immunodeficiency syndrome	0.000107	0.00702	CbGpPWpGaD
Telmisartan—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000107	0.000457	CcSEcCtD
Telmisartan—Anorexia—Lamivudine—acquired immunodeficiency syndrome	0.000107	0.000456	CcSEcCtD
Telmisartan—Insomnia—Saquinavir—acquired immunodeficiency syndrome	0.000106	0.000454	CcSEcCtD
Telmisartan—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	0.000106	0.000453	CcSEcCtD
Telmisartan—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000105	0.000451	CcSEcCtD
Telmisartan—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	0.000105	0.000451	CcSEcCtD
Telmisartan—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.000105	0.00045	CcSEcCtD
Telmisartan—Fatigue—Ritonavir—acquired immunodeficiency syndrome	0.000105	0.000449	CcSEcCtD
Telmisartan—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.000105	0.000448	CcSEcCtD
Telmisartan—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.000105	0.000447	CcSEcCtD
Telmisartan—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.000104	0.000447	CcSEcCtD
Telmisartan—AGTR1—Peptide ligand-binding receptors—CCR5—acquired immunodeficiency syndrome	0.000104	0.00687	CbGpPWpGaD
Telmisartan—Hypotension—Lamivudine—acquired immunodeficiency syndrome	0.000104	0.000447	CcSEcCtD
Telmisartan—ABCB1—HIF-1-alpha transcription factor network—CXCR4—acquired immunodeficiency syndrome	0.000104	0.00685	CbGpPWpGaD
Telmisartan—ABCB1—HIF-1-alpha transcription factor network—CXCL12—acquired immunodeficiency syndrome	0.000104	0.00685	CbGpPWpGaD
Telmisartan—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.000104	0.000446	CcSEcCtD
Telmisartan—Pain—Ritonavir—acquired immunodeficiency syndrome	0.000104	0.000446	CcSEcCtD
Telmisartan—Constipation—Ritonavir—acquired immunodeficiency syndrome	0.000104	0.000446	CcSEcCtD
Telmisartan—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.000104	0.000446	CcSEcCtD
Telmisartan—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.000104	0.000446	CcSEcCtD
Telmisartan—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000104	0.000443	CcSEcCtD
Telmisartan—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	0.000103	0.000442	CcSEcCtD
Telmisartan—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.000103	0.000441	CcSEcCtD
Telmisartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.000102	0.00672	CbGpPWpGaD
Telmisartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.000102	0.00672	CbGpPWpGaD
Telmisartan—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	0.000102	0.000436	CcSEcCtD
Telmisartan—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000102	0.000436	CcSEcCtD
Telmisartan—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.000101	0.000434	CcSEcCtD
Telmisartan—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.000101	0.000433	CcSEcCtD
Telmisartan—Insomnia—Lamivudine—acquired immunodeficiency syndrome	0.000101	0.000433	CcSEcCtD
Telmisartan—Fatigue—Saquinavir—acquired immunodeficiency syndrome	0.000101	0.000433	CcSEcCtD
Telmisartan—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	0.0001	0.00043	CcSEcCtD
Telmisartan—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	0.0001	0.00043	CcSEcCtD
Telmisartan—Pain—Saquinavir—acquired immunodeficiency syndrome	0.0001	0.000429	CcSEcCtD
Telmisartan—Constipation—Saquinavir—acquired immunodeficiency syndrome	0.0001	0.000429	CcSEcCtD
Telmisartan—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	9.97e-05	0.000427	CcSEcCtD
Telmisartan—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	9.97e-05	0.000427	CcSEcCtD
Telmisartan—Vomiting—Zidovudine—acquired immunodeficiency syndrome	9.96e-05	0.000426	CcSEcCtD
Telmisartan—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	9.96e-05	0.000426	CcSEcCtD
Telmisartan—Somnolence—Lamivudine—acquired immunodeficiency syndrome	9.94e-05	0.000425	CcSEcCtD
Telmisartan—Rash—Zidovudine—acquired immunodeficiency syndrome	9.88e-05	0.000423	CcSEcCtD
Telmisartan—Asthenia—Efavirenz—acquired immunodeficiency syndrome	9.88e-05	0.000423	CcSEcCtD
Telmisartan—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	9.87e-05	0.000422	CcSEcCtD
Telmisartan—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	9.84e-05	0.000421	CcSEcCtD
Telmisartan—Headache—Zidovudine—acquired immunodeficiency syndrome	9.81e-05	0.00042	CcSEcCtD
Telmisartan—Pruritus—Efavirenz—acquired immunodeficiency syndrome	9.74e-05	0.000417	CcSEcCtD
Telmisartan—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	9.72e-05	0.000416	CcSEcCtD
Telmisartan—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	9.7e-05	0.000415	CcSEcCtD
Telmisartan—Urticaria—Ritonavir—acquired immunodeficiency syndrome	9.67e-05	0.000414	CcSEcCtD
Telmisartan—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	9.66e-05	0.000413	CcSEcCtD
Telmisartan—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	9.65e-05	0.000413	CcSEcCtD
Telmisartan—Fatigue—Lamivudine—acquired immunodeficiency syndrome	9.64e-05	0.000413	CcSEcCtD
Telmisartan—Dizziness—Indinavir—acquired immunodeficiency syndrome	9.63e-05	0.000412	CcSEcCtD
Telmisartan—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	9.63e-05	0.000412	CcSEcCtD
Telmisartan—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	9.63e-05	0.000412	CcSEcCtD
Telmisartan—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	9.58e-05	0.00041	CcSEcCtD
Telmisartan—Pain—Lamivudine—acquired immunodeficiency syndrome	9.56e-05	0.000409	CcSEcCtD
Telmisartan—Constipation—Lamivudine—acquired immunodeficiency syndrome	9.56e-05	0.000409	CcSEcCtD
Telmisartan—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—acquired immunodeficiency syndrome	9.53e-05	0.00626	CbGpPWpGaD
Telmisartan—Asthenia—Delavirdine—acquired immunodeficiency syndrome	9.45e-05	0.000404	CcSEcCtD
Telmisartan—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	9.42e-05	0.000403	CcSEcCtD
Telmisartan—Pruritus—Delavirdine—acquired immunodeficiency syndrome	9.32e-05	0.000399	CcSEcCtD
Telmisartan—Urticaria—Saquinavir—acquired immunodeficiency syndrome	9.31e-05	0.000399	CcSEcCtD
Telmisartan—Nausea—Zidovudine—acquired immunodeficiency syndrome	9.3e-05	0.000398	CcSEcCtD
Telmisartan—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	9.27e-05	0.000397	CcSEcCtD
Telmisartan—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	9.27e-05	0.000397	CcSEcCtD
Telmisartan—Vomiting—Indinavir—acquired immunodeficiency syndrome	9.26e-05	0.000396	CcSEcCtD
Telmisartan—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	9.21e-05	0.000394	CcSEcCtD
Telmisartan—Rash—Indinavir—acquired immunodeficiency syndrome	9.19e-05	0.000393	CcSEcCtD
Telmisartan—Dermatitis—Indinavir—acquired immunodeficiency syndrome	9.18e-05	0.000393	CcSEcCtD
Telmisartan—AGTR1—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	9.16e-05	0.00602	CbGpPWpGaD
Telmisartan—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	9.14e-05	0.000391	CcSEcCtD
Telmisartan—Headache—Indinavir—acquired immunodeficiency syndrome	9.13e-05	0.000391	CcSEcCtD
Telmisartan—Dizziness—Efavirenz—acquired immunodeficiency syndrome	9.1e-05	0.00039	CcSEcCtD
Telmisartan—ABCB1—Allograft Rejection—CXCL12—acquired immunodeficiency syndrome	9.03e-05	0.00593	CbGpPWpGaD
Telmisartan—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	9.01e-05	0.000386	CcSEcCtD
Telmisartan—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	8.97e-05	0.000384	CcSEcCtD
Telmisartan—Urticaria—Lamivudine—acquired immunodeficiency syndrome	8.88e-05	0.00038	CcSEcCtD
Telmisartan—AGTR1—Allograft Rejection—TNF—acquired immunodeficiency syndrome	8.87e-05	0.00583	CbGpPWpGaD
Telmisartan—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	8.84e-05	0.000378	CcSEcCtD
Telmisartan—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	8.84e-05	0.000378	CcSEcCtD
Telmisartan—Vomiting—Efavirenz—acquired immunodeficiency syndrome	8.75e-05	0.000375	CcSEcCtD
Telmisartan—Asthenia—Ritonavir—acquired immunodeficiency syndrome	8.74e-05	0.000374	CcSEcCtD
Telmisartan—PPARG—Developmental Biology—ACTG1—acquired immunodeficiency syndrome	8.72e-05	0.00573	CbGpPWpGaD
Telmisartan—Dizziness—Delavirdine—acquired immunodeficiency syndrome	8.71e-05	0.000373	CcSEcCtD
Telmisartan—Rash—Efavirenz—acquired immunodeficiency syndrome	8.68e-05	0.000371	CcSEcCtD
Telmisartan—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	8.67e-05	0.000371	CcSEcCtD
Telmisartan—Nausea—Indinavir—acquired immunodeficiency syndrome	8.65e-05	0.00037	CcSEcCtD
Telmisartan—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	8.64e-05	0.00037	CcSEcCtD
Telmisartan—Headache—Efavirenz—acquired immunodeficiency syndrome	8.62e-05	0.000369	CcSEcCtD
Telmisartan—Pruritus—Ritonavir—acquired immunodeficiency syndrome	8.62e-05	0.000369	CcSEcCtD
Telmisartan—Asthenia—Saquinavir—acquired immunodeficiency syndrome	8.41e-05	0.00036	CcSEcCtD
Telmisartan—Vomiting—Delavirdine—acquired immunodeficiency syndrome	8.37e-05	0.000358	CcSEcCtD
Telmisartan—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	8.33e-05	0.000357	CcSEcCtD
Telmisartan—Rash—Delavirdine—acquired immunodeficiency syndrome	8.3e-05	0.000355	CcSEcCtD
Telmisartan—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	8.3e-05	0.000355	CcSEcCtD
Telmisartan—Pruritus—Saquinavir—acquired immunodeficiency syndrome	8.29e-05	0.000355	CcSEcCtD
Telmisartan—AGTR1—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	8.28e-05	0.00544	CbGpPWpGaD
Telmisartan—Headache—Delavirdine—acquired immunodeficiency syndrome	8.25e-05	0.000353	CcSEcCtD
Telmisartan—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	8.24e-05	0.000353	CcSEcCtD
Telmisartan—AGTR1—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	8.18e-05	0.00538	CbGpPWpGaD
Telmisartan—Nausea—Efavirenz—acquired immunodeficiency syndrome	8.18e-05	0.00035	CcSEcCtD
Telmisartan—Dizziness—Ritonavir—acquired immunodeficiency syndrome	8.05e-05	0.000345	CcSEcCtD
Telmisartan—Asthenia—Lamivudine—acquired immunodeficiency syndrome	8.02e-05	0.000343	CcSEcCtD
Telmisartan—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	8.02e-05	0.000343	CcSEcCtD
Telmisartan—Pruritus—Lamivudine—acquired immunodeficiency syndrome	7.91e-05	0.000339	CcSEcCtD
Telmisartan—Nausea—Delavirdine—acquired immunodeficiency syndrome	7.82e-05	0.000335	CcSEcCtD
Telmisartan—AGTR1—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	7.79e-05	0.00512	CbGpPWpGaD
Telmisartan—AGTR1—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	7.79e-05	0.00512	CbGpPWpGaD
Telmisartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	7.78e-05	0.00511	CbGpPWpGaD
Telmisartan—Dizziness—Saquinavir—acquired immunodeficiency syndrome	7.75e-05	0.000332	CcSEcCtD
Telmisartan—Vomiting—Ritonavir—acquired immunodeficiency syndrome	7.74e-05	0.000331	CcSEcCtD
Telmisartan—Rash—Ritonavir—acquired immunodeficiency syndrome	7.68e-05	0.000329	CcSEcCtD
Telmisartan—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	7.67e-05	0.000328	CcSEcCtD
Telmisartan—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	7.65e-05	0.000327	CcSEcCtD
Telmisartan—Headache—Ritonavir—acquired immunodeficiency syndrome	7.63e-05	0.000327	CcSEcCtD
Telmisartan—AGTR1—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	7.61e-05	0.005	CbGpPWpGaD
Telmisartan—Vomiting—Saquinavir—acquired immunodeficiency syndrome	7.45e-05	0.000319	CcSEcCtD
Telmisartan—AGTR1—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	7.42e-05	0.00487	CbGpPWpGaD
Telmisartan—Dizziness—Lamivudine—acquired immunodeficiency syndrome	7.39e-05	0.000316	CcSEcCtD
Telmisartan—Rash—Saquinavir—acquired immunodeficiency syndrome	7.39e-05	0.000316	CcSEcCtD
Telmisartan—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	7.38e-05	0.000316	CcSEcCtD
Telmisartan—Headache—Saquinavir—acquired immunodeficiency syndrome	7.34e-05	0.000314	CcSEcCtD
Telmisartan—PPARG—Signaling events mediated by HDAC Class I—TNF—acquired immunodeficiency syndrome	7.28e-05	0.00478	CbGpPWpGaD
Telmisartan—Nausea—Ritonavir—acquired immunodeficiency syndrome	7.23e-05	0.00031	CcSEcCtD
Telmisartan—Vomiting—Lamivudine—acquired immunodeficiency syndrome	7.11e-05	0.000304	CcSEcCtD
Telmisartan—Rash—Lamivudine—acquired immunodeficiency syndrome	7.05e-05	0.000302	CcSEcCtD
Telmisartan—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	7.04e-05	0.000301	CcSEcCtD
Telmisartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	7.01e-05	0.00461	CbGpPWpGaD
Telmisartan—Headache—Lamivudine—acquired immunodeficiency syndrome	7.01e-05	0.0003	CcSEcCtD
Telmisartan—Nausea—Saquinavir—acquired immunodeficiency syndrome	6.96e-05	0.000298	CcSEcCtD
Telmisartan—SLCO1B3—Metabolism—TAT—acquired immunodeficiency syndrome	6.9e-05	0.00453	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	6.88e-05	0.00452	CbGpPWpGaD
Telmisartan—ABCB1—Allograft Rejection—IL10—acquired immunodeficiency syndrome	6.84e-05	0.0045	CbGpPWpGaD
Telmisartan—ABCB1—Allograft Rejection—CD40LG—acquired immunodeficiency syndrome	6.84e-05	0.0045	CbGpPWpGaD
Telmisartan—PPARG—Transcriptional regulation of white adipocyte differentiation—TNF—acquired immunodeficiency syndrome	6.74e-05	0.00443	CbGpPWpGaD
Telmisartan—ABCB1—Allograft Rejection—IL4—acquired immunodeficiency syndrome	6.66e-05	0.00437	CbGpPWpGaD
Telmisartan—Nausea—Lamivudine—acquired immunodeficiency syndrome	6.64e-05	0.000284	CcSEcCtD
Telmisartan—ABCB1—Allograft Rejection—HLA-B—acquired immunodeficiency syndrome	6.51e-05	0.00428	CbGpPWpGaD
Telmisartan—AGTR1—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	5.92e-05	0.00389	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—TAT—acquired immunodeficiency syndrome	5.89e-05	0.00387	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—AGPS—acquired immunodeficiency syndrome	5.87e-05	0.00385	CbGpPWpGaD
Telmisartan—AGTR1—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	5.34e-05	0.00351	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—CCNT1—acquired immunodeficiency syndrome	5.15e-05	0.00338	CbGpPWpGaD
Telmisartan—SLCO1B3—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	5.05e-05	0.00332	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—AGPS—acquired immunodeficiency syndrome	5.01e-05	0.00329	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	4.7e-05	0.00309	CbGpPWpGaD
Telmisartan—AGTR1—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	4.68e-05	0.00308	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	4.54e-05	0.00298	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	4.49e-05	0.00295	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	4.49e-05	0.00295	CbGpPWpGaD
Telmisartan—PPARG—Adipogenesis—TNF—acquired immunodeficiency syndrome	4.44e-05	0.00291	CbGpPWpGaD
Telmisartan—AGTR1—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	4.4e-05	0.00289	CbGpPWpGaD
Telmisartan—AGTR1—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	4.4e-05	0.00289	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—TAT—acquired immunodeficiency syndrome	4.29e-05	0.00282	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	4.25e-05	0.00279	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	4.06e-05	0.00267	CbGpPWpGaD
Telmisartan—ABCB1—Allograft Rejection—IFNG—acquired immunodeficiency syndrome	4.02e-05	0.00264	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	4e-05	0.00263	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	4e-05	0.00263	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—AGPS—acquired immunodeficiency syndrome	3.65e-05	0.0024	CbGpPWpGaD
Telmisartan—PPARG—Adipogenesis—IL6—acquired immunodeficiency syndrome	3.58e-05	0.00235	CbGpPWpGaD
Telmisartan—ABCB1—Allograft Rejection—IL2—acquired immunodeficiency syndrome	3.58e-05	0.00235	CbGpPWpGaD
Telmisartan—AGTR1—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	3.35e-05	0.0022	CbGpPWpGaD
Telmisartan—AGTR1—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	3.3e-05	0.00217	CbGpPWpGaD
Telmisartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	3.21e-05	0.00211	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	3.04e-05	0.002	CbGpPWpGaD
Telmisartan—AGTR1—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	3.02e-05	0.00198	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	2.99e-05	0.00197	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	2.78e-05	0.00182	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	2.74e-05	0.0018	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	2.7e-05	0.00178	CbGpPWpGaD
Telmisartan—ABCB1—Allograft Rejection—TNF—acquired immunodeficiency syndrome	2.6e-05	0.00171	CbGpPWpGaD
Telmisartan—SLCO1B3—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	2.57e-05	0.00169	CbGpPWpGaD
Telmisartan—PPARG—Circadian rythm related genes—IL6—acquired immunodeficiency syndrome	2.53e-05	0.00166	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	2.51e-05	0.00165	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—TAT—acquired immunodeficiency syndrome	2.38e-05	0.00156	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	2.36e-05	0.00155	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	2.36e-05	0.00155	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—TAT—acquired immunodeficiency syndrome	2.32e-05	0.00152	CbGpPWpGaD
Telmisartan—PPARG—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	2.3e-05	0.00151	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—AGPS—acquired immunodeficiency syndrome	2.02e-05	0.00133	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—AGPS—acquired immunodeficiency syndrome	1.97e-05	0.0013	CbGpPWpGaD
Telmisartan—ABCC2—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	1.84e-05	0.00121	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.8e-05	0.00118	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.77e-05	0.00116	CbGpPWpGaD
Telmisartan—AGTR1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.74e-05	0.00115	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.62e-05	0.00106	CbGpPWpGaD
Telmisartan—ABCG2—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	1.6e-05	0.00105	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.58e-05	0.00104	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—TNF—acquired immunodeficiency syndrome	1.52e-05	0.001	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—acquired immunodeficiency syndrome	1.29e-05	0.000844	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—IL6—acquired immunodeficiency syndrome	1.23e-05	0.000808	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—ALB—acquired immunodeficiency syndrome	1.2e-05	0.000791	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—ALB—acquired immunodeficiency syndrome	1.03e-05	0.000675	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	9.35e-06	0.000614	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	9.31e-06	0.000612	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	9.3e-06	0.000611	CbGpPWpGaD
Telmisartan—ABCB1—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	8.64e-06	0.000568	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—ALB—acquired immunodeficiency syndrome	7.48e-06	0.000492	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	5.5e-06	0.000361	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—ALB—acquired immunodeficiency syndrome	4.15e-06	0.000272	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—ALB—acquired immunodeficiency syndrome	4.05e-06	0.000266	CbGpPWpGaD
